Cochrane · systematic review · CD012889

Non‐invasive positive pressure ventilation for central sleep apnoea in adults

Pinto, ACPereira Nunes, Rocha, A, Drager, LF, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
48
current version
GRADE rated
18
No studies
30
Included studies
NR
No studies 30 · 62.5%Ungraded 0 · 0%Very low 3 · 6.3%Low 14 · 29.2%Moderate 1 · 2.1%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Continuous positive airway pressure (CPAP) plus best supportive care versus best supportive care for central sleep apnoea associated with chronic heart failure

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI ‐ after 3 months Number of participants: 205(1 RCT)
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Cardiovascular mortality ‐ after 24 months Number of participants: 258(1 RCT)
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
RR 1.17 [0.68, 2.02]NRLow
Downgraded: risk of bias, imprecision
Serious adverse events
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRNo studies
Quality of sleep
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRNo studies
Quality of life
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRNo studies
AHI ‐ after up to 3 months Number of participants: 264(4 RCT)
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
All‐cause mortality ‐ after 24 months Number of participants: 287(2 RCTs)
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
RR 1.14 [0.83, 1.56]NRVery low
Downgraded: risk of bias, imprecision
Time to life‐saving cardiovascular intervention (
Continuous positive airway pressure (CPAP) plus best supportive care vs best supportive care
no estimate extractedNRLow
Downgraded: risk of bias, imprecision

Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for central sleep apnoea associated with chronic heart failure

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Cardiovascular mortality
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Serious adverse events
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Quality of sleep
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Quality of life
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
AHI ‐ after 6 months Number of participants: 17(1 RCT)
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
All‐cause mortality
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Time to life‐saving cardiovascular intervention
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies

Adaptive servo ventilation (ASV) versus bilevel ventilation for central sleep apnoea associated with chronic heart failure

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI ‐ after 6 weeks Number of participants: 30(1 RCT)
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Cardiovascular mortality
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Serious adverse events
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Quality of sleep
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Quality of life
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
AHI ‐ after 6 weeks Number of participants: 30(1 RCT)
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRVery low
Downgraded: risk of bias, imprecision
All‐cause mortality
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Time to life‐saving cardiovascular intervention
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies

Adaptive servo ventilation (ASV) versus continuous positive airway pressure (CPAP) for CPAP‐induced central sleep apnoea

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI ‐ after 3 months Number of participants: 60(1 RCT)
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Cardiovascular mortality
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Serious adverse events
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Quality of sleep
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Quality of life ‐ after 3 months Number of participants: 61(1 RCT)
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
AHI ‐ after 3 months Number of participants: 60(1 RCT)
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
All‐cause mortality
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies
Time to life‐saving cardiovascular intervention
Adaptive servo ventilation (ASV) vs continuous positive airway pressure (CPAP)
no estimate extractedNRNo studies

Adaptive servo ventilation (ASV) versus bilevel ventilation for CPAP‐induced central sleep apnoea

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI ‐ after 6 weeks Number of participants: 30(1 RCT)
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
Cardiovascular mortality
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Serious adverse events
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Quality of sleep
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Quality of life
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
AHI ‐ after 6 weeks Number of participants: 30(1 RCT)
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
All‐cause mortality
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies
Time to life‐saving cardiovascular intervention
Adaptive servo ventilation (ASV) vs bilevel ventilation
no estimate extractedNRNo studies

Adaptive servo ventilation (ASV) plus best supportive care versus best supportive care alone or inactive control for central sleep apnoea associated with chronic heart failure

8 questions
OutcomeEffectEvidenceStatus / GRADE
Central AHI
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRNo studies
Cardiovascular mortality ‐ up to 80 months Number of participants: 1325(1 RCT)
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
RR 1.25 [1.04, 1.49]NRModerate
Downgraded: risk of bias, imprecision
Serious adverse events
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRNo studies
Quality of sleep
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRNo studies
Quality of life ‐ after 48 months Number of participants: 1325(1 RCT)
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
AHI ‐ after 6 months Number of participants: 30(1 RCT)
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRLow
Downgraded: risk of bias, imprecision
All‐cause mortality ‐ up to 80 months Number of participants: 1355(2 RCTs)
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
RR 0.56 [0.06, 4.93]NRLow
Downgraded: risk of bias, imprecision
Time to life‐saving cardiovascular intervention
Adaptive servo ventilation (ASV) plus best supportive care vs best supportive care alone or inactive control
no estimate extractedNRNo studies